» Articles » PMID: 30414963

RNA-Mediated Dimerization of the Human Deoxycytidine Deaminase APOBEC3H Influences Enzyme Activity and Interaction with Nucleic Acids

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2018 Nov 12
PMID 30414963
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Human APOBEC3H is a single-stranded (ss)DNA deoxycytidine deaminase that inhibits replication of retroelements and HIV-1 in CD4+ T cells. When aberrantly expressed in lung or breast tissue, APOBEC3H can contribute to cancer mutagenesis. These different activities are carried out by different haplotypes of APOBEC3H. Here we studied APOBEC3H haplotype II, which is able to restrict HIV-1 replication and retroelements. We determined how the dimerization mechanism, which is mediated by a double-stranded RNA molecule, influenced interactions with and activity on ssDNA. The data demonstrate that the cellular RNA bound by APOBEC3H does not completely inhibit enzyme activity, in contrast to other APOBEC family members. Despite degradation of the cellular RNA, an approximately 12-nt RNA remains bound to the enzyme, even in the presence of ssDNA. The RNA-mediated dimer is disrupted by mutating W115 on loop 7 or R175 and R176 on helix 6, but this also disrupts protein stability. In contrast, mutation of Y112 and Y113 on loop 7 also destabilizes RNA-mediated dimerization but results in a stable enzyme. Mutants unable to bind cellular RNA are unable to bind RNA oligonucleotides, oligomerize, and deaminate ssDNA in vitro, but ssDNA binding is retained. Comparison of A3H wild type and Y112A/Y113A by fluorescence polarization, single-molecule optical tweezer, and atomic force microscopy experiments demonstrates that RNA-mediated dimerization alters the interactions of A3H with ssDNA and other RNA molecules. Altogether, the biochemical analysis demonstrates that RNA binding is integral to APOBEC3H function.

Citing Articles

Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I.

Yousefi M, Annan Sudarsan A, Gaba A, Chelico L Viruses. 2023; 15(2).

PMID: 36851677 PMC: 9960753. DOI: 10.3390/v15020463.


Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.

Gaba A, Flath B, Chelico L Viruses. 2021; 13(6).

PMID: 34200141 PMC: 8228377. DOI: 10.3390/v13061084.


Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms.

McDonnell M, Karvonen S, Gaba A, Flath B, Chelico L, Emerman M PLoS Pathog. 2021; 17(6):e1009523.

PMID: 34170969 PMC: 8266076. DOI: 10.1371/journal.ppat.1009523.


APOBEC1 cytosine deaminase activity on single-stranded DNA is suppressed by replication protein A.

Wong L, Vizeacoumar F, Vizeacoumar F, Chelico L Nucleic Acids Res. 2020; 49(1):322-339.

PMID: 33330905 PMC: 7797036. DOI: 10.1093/nar/gkaa1201.


The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.

Granadillo Rodriguez M, Flath B, Chelico L Open Biol. 2020; 10(12):200188.

PMID: 33292100 PMC: 7776566. DOI: 10.1098/rsob.200188.


References
1.
Jameson D, Ross J . Fluorescence polarization/anisotropy in diagnostics and imaging. Chem Rev. 2010; 110(5):2685-708. PMC: 2868933. DOI: 10.1021/cr900267p. View

2.
Chelico L, Pham P, Calabrese P, Goodman M . APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA. Nat Struct Mol Biol. 2006; 13(5):392-9. DOI: 10.1038/nsmb1086. View

3.
Huthoff H, Autore F, Gallois-Montbrun S, Fraternali F, Malim M . RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog. 2009; 5(3):e1000330. PMC: 2646141. DOI: 10.1371/journal.ppat.1000330. View

4.
Kim E, Lorenzo-Redondo R, Little S, Chung Y, Phalora P, Berry I . Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection. PLoS Pathog. 2014; 10(7):e1004281. PMC: 4117599. DOI: 10.1371/journal.ppat.1004281. View

5.
Mulder L, Harari A, Simon V . Cytidine deamination induced HIV-1 drug resistance. Proc Natl Acad Sci U S A. 2008; 105(14):5501-6. PMC: 2291111. DOI: 10.1073/pnas.0710190105. View